Related references
Note: Only part of the references are listed.Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2019)
Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes
Kelly D. Myers et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2019)
Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque The Multi-Ethnic Study of Atherosclerosis
Steven Shea et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease
Anna Helgadottir et al.
EUROPEAN HEART JOURNAL (2018)
Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study
Dennis T. Ko et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study
R. Kannan Mutharasan et al.
JOURNAL OF LIPID RESEARCH (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
NMR Structure of the C-Terminal Transmembrane Domain of the HDL Receptor, SR-BI, and a Functionally Relevant Leucine Zipper Motif
Alexandra C. Chadwick et al.
STRUCTURE (2017)
Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studies
Karen S. Conrad et al.
NATURE COMMUNICATIONS (2017)
SR-BI Mediated Transcytosis of HDL in Brain Microvascular Endothelial Cells Is Independent of Caveolin, Clathrin, and PDZK1
Karen Y. Fung et al.
FRONTIERS IN PHYSIOLOGY (2017)
Compressed glassy carbon: An ultrastrong and elastic interpenetrating graphene network
Meng Hu et al.
SCIENCE ADVANCES (2017)
Clinical application of whole-exome sequencing across clinical indications
Kyle Retterer et al.
GENETICS IN MEDICINE (2016)
The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes
G. C. P. van Zundert et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Statin-Associated Side Effects
Paul D. Thompson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
Paolo Zanoni et al.
SCIENCE (2016)
Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen
Arnaud Carpentier et al.
STEM CELL RESEARCH (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
The Phyre2 web portal for protein modeling, prediction and analysis
Lawrence A. Kelley et al.
NATURE PROTOCOLS (2015)
I-TASSER server: new development for protein structure and function predictions
Jianyi Yang et al.
NUCLEIC ACIDS RESEARCH (2015)
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
Danish Saleheen et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
YASARA View-molecular graphics for all devices-from smartphones to workstations
Elmar Krieger et al.
BIOINFORMATICS (2014)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
Iris Postmus et al.
NATURE COMMUNICATIONS (2014)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans
L. R. Brunham et al.
CLINICAL GENETICS (2011)
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol A Randomized Controlled Trial
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Glycine Dimerization Motif in the N-terminal Transmembrane Domain of the High Density Lipoprotein Receptor SR-BI Required for Normal Receptor Oligomerization and Lipid Transport
Leonid Gaidukov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Clinical implications of discordance between low-density lipoprotein cholesterol and particle number
James D. Otvos et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Association of Scavenger Receptor Class B Type I Polymorphisms With Subclinical Atherosclerosis The Multi-Ethnic Study of Atherosclerosis
Adam C. Naj et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease.
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
HDL particle size and the risk of coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study
Benoit J. Arsenault et al.
ATHEROSCLEROSIS (2009)
High-Density Lipoprotein Transport Through Aortic Endothelial Cells Involves Scavenger Receptor BI and ATP-Binding Cassette Transporter G1
Lucia Rohrer et al.
CIRCULATION RESEARCH (2009)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Scavenger receptor class B type I polymorphisms and peripheral arterial disease (vol 56, pg 1135, 2007)
Andreas Ritsch et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Scavenger receptor class B type I polymorphisms and peripheral arterial disease
Andreas Ritsch et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Scavenger receptor class B, type I (SR-BI) horno-dirnerizes via its C-terminal region: Fluorescence resonance energy transfer analysis
Daisy Sahoo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
SR-BI-mediated high density lipoprotein (HDL) endocytosis leads to HDL resecretion facilitating cholesterol efflux
TA Pagler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Share Paper
